November 04, 2025

Get In Touch

Cabinet Approves Bill On Biotechnology Centre In Faridabad

New Delhi: The union cabinet, at a meeting chaired by Prime Minister Narendra Modi, gave its approval for introduction of a bill concerning Regional Biotechnology centre in Faridabad to grant autonomous status to it.

“The objective of the bill is to provide a legal status to the centre so as to function independently as an autonomous body and also an institution of national importance for education, training and research in the areas of biotechnology,” an official release said.

It said the centre has already been established by an executive order of the government in November 2008 and is operational at present at the NCR Biotech Science Cluster, Faridabad.

The centre is a regional hub for interdisciplinary education, training and research in biotechnology with emphasis on novel education programmes relevant to industry including bio-drug discovery science, nano-science and medicine, imaging techniques, designer crops, bioengineering and bio-materials and intellectual property.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!